Description
Development of a plant-derived candidate universal influenza vaccine ready for clinical development
Amendment chain · 3 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $2,515,000 at start, $1,915,000 after amendment #6 (−$600,000).
- #02019-01-01$2,515,000
- #22020-09-04$2,515,000
- #62022-06-01$1,915,000-$600,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2019-01-01(start date) | $2,515,000 | — | Development of a plant-derived candidate universal influenza vaccine ready for clinical development |
| #2 amendment | 2020-09-04 | $2,515,000 | +$0 | Development of a plant-derived candidate universal influenza vaccine ready for clinical development |
| #6 amendment | 2022-06-01 | $1,915,000 | −$600,000 | Development of a plant-derived candidate universal influenza vaccine ready for clinical development |
Related records · 6
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 872308499)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 033-2020-2021-Q3-815733 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SIF Stream3- Attraction | $169,872,474 | FY2020 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2018-2019-Q4-920200 · retrieved 2026-11-13.